中文 | English
Return
Total: 22 , 1/3
Show Home Prev Next End page: GO
Author:( Shuxiang CUI)

1.Reactive oxygen species and tumor therapy

Houli ZHANG ; Shuxiang CUI

Journal of International Oncology 2012;39(7):504-507

2.Animal models of cancer metastasis

Jun LIU ; Shuxiang CUI

Journal of International Oncology 2013;(6):412-415

3.Nasopharyngeal hemorrhage after radiotherapy of nasopharyngeal carcinoma

Shuxiang CUI ; Yingxuan WANG

Chinese Journal of Radiation Oncology 1993;0(03):-

4.Des-γ-carboxy prothrombin in hepatocellular carcinoma

Xuechuan LI ; Wei TANG ; Shuxiang CUI

Journal of International Oncology 2008;35(8):612-615

5.Animal models of lung cancer

Jun LIU ; Jing JIN ; Shuxiang CUI

Journal of International Oncology 2013;40(10):758-761

6.Clinical Significance of Measurement of Urinary Leukotrience E_4 (LTE_4) in Patients with Asthma.

Yanhong CUI ; Shuxiang HAN ; Minghui WANG

Journal of Medical Research 2006;0(02):-

7.Aminopeptidase N and its inhibitors and carcinoma

Keling PEI ; Houli ZHANG ; Shuxiang CUI

Journal of International Oncology 2012;39(3):169-171,233

8.CLINICAL OBSERVATION IN HYPOXY-RADIOTHERAPY OF LUNG CANCER

Shuxiang CUI ; Suoting WANG ; Dianjiu WU

Chinese Journal of Radiation Oncology 1992;0(01):-

9.The studies of the pharmacodynamics of antineoplaston A_(10)

Renjiang YU ; Shuxiang CUI ; Ling ZHOU ; Xianjun QU

Chinese Pharmacological Bulletin 1986;0(05):-

10.Clinical study on the effect of Yangyinjiandu decoction on acute raditation esophagitis

Ping FANG ; Fawei WANG ; Shuxiang CUI ; Shunchang JIAO

Chinese Journal of Radiation Oncology 2005;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 22 , 1/3 Show Home Prev Next End page: GO